The possibilities of using the inhibitors of matrix metalloproteinases for keratoplasty

Q4 Medicine
K. V. Sirotkina, E. V. Chentsova
{"title":"The possibilities of using the inhibitors of matrix metalloproteinases for keratoplasty","authors":"K. V. Sirotkina, E. V. Chentsova","doi":"10.23873/2074-0506-2023-15-2-347-358","DOIUrl":null,"url":null,"abstract":"Introduction . The review is devoted to the actual problem of treating patients with keratolysis. The role of matrix metalloproteinases in the pathogenesis of cornea and corneal graft melting is discussed as well as the practical experience of using synthetic metalloproteinase inhibitors in various branches of medicine and in ophthalmology, in particular. In the field of eye diseases, the search for effective methods for the treatment of corneal injuries of various origins, as well as its post-transplant complications, has been underway for a long time. Recent studies have shown that local imbalance of matrix metalloproteinases and their inhibitors system, as well as the immune system status, may play the main role in the outcome of urgent keratoplasty, and the use of synthetic metalloproteinase inhibitors can significantly improve the biological result of the donor cornea transplant. The role of platelets in the regulation of the proteolytic system has not been fully studied. However, some literature data on the platelet-associated inhibitor of metalloproteinases and the use of platelet-rich plasma to correct the collagenolytic activity of enzymes are of great interest to ophthalmologists, due to therapeutic efficacy and simple method of producing its production the autologous platelet-rich plasma.The present brief literature review covers the pathogenesis and clinical features of keratolysis, factors which can affect the outcome of urgent keratoplasty, describes the features of matrix metalloproteinases, their inhibitors, and the plateletrich plasma as a potential endogenous source of a tissue inhibitor of matrix metalloproteinases. Aim . To evaluate the possibility of using inhibitors of matrix metalloproteinases for keratoplasty based on a literature review. Material and methods . To write the review article, we have made the search in the homeland eLibrary.RU database and in the PubMed resource database to select the articles on the topic published in the period from 1985 to 2022.","PeriodicalId":31706,"journal":{"name":"Transplantologia","volume":"213 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23873/2074-0506-2023-15-2-347-358","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction . The review is devoted to the actual problem of treating patients with keratolysis. The role of matrix metalloproteinases in the pathogenesis of cornea and corneal graft melting is discussed as well as the practical experience of using synthetic metalloproteinase inhibitors in various branches of medicine and in ophthalmology, in particular. In the field of eye diseases, the search for effective methods for the treatment of corneal injuries of various origins, as well as its post-transplant complications, has been underway for a long time. Recent studies have shown that local imbalance of matrix metalloproteinases and their inhibitors system, as well as the immune system status, may play the main role in the outcome of urgent keratoplasty, and the use of synthetic metalloproteinase inhibitors can significantly improve the biological result of the donor cornea transplant. The role of platelets in the regulation of the proteolytic system has not been fully studied. However, some literature data on the platelet-associated inhibitor of metalloproteinases and the use of platelet-rich plasma to correct the collagenolytic activity of enzymes are of great interest to ophthalmologists, due to therapeutic efficacy and simple method of producing its production the autologous platelet-rich plasma.The present brief literature review covers the pathogenesis and clinical features of keratolysis, factors which can affect the outcome of urgent keratoplasty, describes the features of matrix metalloproteinases, their inhibitors, and the plateletrich plasma as a potential endogenous source of a tissue inhibitor of matrix metalloproteinases. Aim . To evaluate the possibility of using inhibitors of matrix metalloproteinases for keratoplasty based on a literature review. Material and methods . To write the review article, we have made the search in the homeland eLibrary.RU database and in the PubMed resource database to select the articles on the topic published in the period from 1985 to 2022.
基质金属蛋白酶抑制剂用于角膜移植术的可能性
介绍。本文就角化患者的实际治疗问题进行综述。本文讨论了基质金属蛋白酶在角膜发病机制和角膜移植物融化中的作用,以及在医学和眼科的各个分支中使用合成金属蛋白酶抑制剂的实践经验。在眼病领域,长期以来一直在寻找治疗各种来源的角膜损伤及其移植后并发症的有效方法。最近的研究表明,基质金属蛋白酶及其抑制剂系统的局部失衡以及免疫系统状态可能对紧急角膜移植的结果起主要作用,使用合成金属蛋白酶抑制剂可显著改善供体角膜移植的生物学结果。血小板在调节蛋白水解系统中的作用尚未得到充分的研究。然而,一些关于血小板相关的金属蛋白酶抑制剂和利用富血小板血浆纠正酶的胶原溶解活性的文献资料引起了眼科医生的极大兴趣,因为其治疗效果好,而且制备方法简单,即自体富血小板血浆。本文简要综述了角膜溶解的发病机制和临床特征,影响紧急角膜移植结果的因素,描述了基质金属蛋白酶及其抑制剂的特征,以及富血小板血浆作为基质金属蛋白酶组织抑制剂的潜在内源性来源。的目标。在文献综述的基础上,评价基质金属蛋白酶抑制剂用于角膜移植术的可能性。材料和方法。为了写这篇评论文章,我们在国内的图书馆进行了搜索。RU数据库和PubMed资源数据库中选择1985年至2022年期间发表的关于该主题的文章。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Transplantologia
Transplantologia Medicine-Transplantation
CiteScore
0.50
自引率
0.00%
发文量
32
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信